BCRP Inhibitor IV, YHO-13351 (Diethylaminoacetic Acid, 1-(5-((Z)-2-cyano-2- (3,4-dimethoxyphenyl)vinyl)thiophen-2-yl)piperidin-4-yl ester, Methanesulfonate)

Produktübersicht

• Artikelname: BCRP Inhibitor IV, YHO-13351 (Diethylaminoacetic Acid, 1-(5-((Z)-2-cyano-2- (3,4-dimethoxyphenyl)vinyl)thiophen-2-yl)piperidin-4-yl ester, Methanesulfonate)
• Artikelnummer: USB-217212
• Hersteller Artikelnummer: 217212
• Alternativnummer: USB-217212-25
• Hersteller: US Biological
• Kategorie: Biochemikalien

Produktbeschreibung

An in vivo bioavailable (~87%, t1/2 <5 mins. during p.o. and i.v. administration) and highly water soluble ( >100mg/ml) diethylaminoacetate prodrug of YHO-13177 that reverses BCRP-mediated irinotecan resistance in P388/BCRP and HCT116/BCRP xenograft mouse models, and suppresses tumor growth and significantly enhances the survival (100 or 200mg/kg, i.p.). Synonyms: Diethylaminoacetic acid, 1-(5-((Z)-2-cyano-2- (3,4-dimethoxyphenyl)vinyl)thiophen-2-yl)piperidin-4-yl ester, Methanesulfonate Formula: C26H33N3O4S CH3SO3H Molecular Weight: 579.7 Solubility: H2O (25mg/ml) Storage and Stability: Store at -20C under inert atmosphere. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

Produkteigenschaften

• Molekulargewicht: 579.7
• Reinheit: 97% (HPLC)
• Formulierung: Yellow solid.